Farms.com Home   News

USDA Announces Major Investment In Meat Processing Capacity, Meant to Stir Competition, Strengthen Supply Lines

By William Padmore

The USDA has announced it will use $500 million of the nearly $2 trillion American Rescue Plan to expand meat processing capacity across the nation.

At a press conference in Council Bluffs, Iowa Friday, Ag Secretary Tom Vilsack said the funds are intended to increase competition in the processing industry and strengthen resilience in the food supply chain.

"What it's going to do is it's first and foremost going to create an opportunity, then to reverse what's happening today, out in the countryside, where producers are having to sell their cattle at a loss, only to learn the processors end up taking that cattle and generating a profit,” said Vilsack. “Seems to me, in fairness, the profit ought to go both ways.”

In addition to helping build new processing facilities, Vilsack says existing small and medium processors will receive $55 million in aid.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.